Immune checkpoint inhibitors

Sensitivity to immune checkpoint inhibitors in BRAF/MEK inhibitor refractory melanoma
Riyaben P Patel, Lydia Rui Jia Lim, Reem Saleh, Darius Schenk, Michael K Lee, Emily Lelliott, Aparna D Rao, Shaghayegh Arabi, Lorey Smith, Anna S Trigos, Nicole Haynes, Grant A McArthur, Karen E Sheppard

Journal for ImmunoTherapy of Cancer May 2025, 13 (5) e011551; DOI: 10.1136/jitc-2025-011551
Associations between immune checkpoint inhibitor response, immune-related adverse events, and steroid use in RADIOHEAD: a prospective pan-tumor cohort study
Zoe Quandt, Anastasia Lucas, Samantha I Liang, EnJun Yang, Samantha Stone, Muhammad Zaki Hidayatullah Fadlullah, Nicholas L Bayless, Sara Siebel Marr, Marshall A Thompson, Lacey J Padron, Samantha Bucktrout, Lisa H Butterfield, Aik Choon Tan, Kevan C Herold, Jeffrey A Bluestone, Mark S Anderson, Christine N Spencer, Arabella Young, John E Connolly

Journal for ImmunoTherapy of Cancer May 2025, 13 (5) e011545; DOI: 10.1136/jitc-2025-011545
Onset and progression of atherosclerosis in patients with melanoma treated with immune checkpoint inhibitors
Daan C H van Dorst, Tom J J Uyl, Astrid A M Van der Veldt, Timy Andrawes, Arjen Joosse, Esther Oomen-De Hoop, Alexander HJ Danser, Ron H J Mathijssen, Daniel Bos, Jorie Versmissen

Journal for ImmunoTherapy of Cancer Apr 2025, 13 (4) e011226; DOI: 10.1136/jitc-2024-011226
Quality of life, neurocognitive functioning, psychological issues, sexuality and comorbidity more than 2 years after commencing immune checkpoint inhibitor treatment
Wellington Candido, Annemarie Cecile Eggen, Mathilde Jalving, Ingeborg Bosma, Reinate D Horinga, Kelly C van Heuvelen, T Jeroen N Hiltermann, Sjoukje Oosting, Emoke Racz, Melanie M van der Klauw, Anna K L Reyners, Janine Nuver

Journal for ImmunoTherapy of Cancer Mar 2025, 13 (3) e011168; DOI: 10.1136/jitc-2024-011168
Cardiac MRI study of adverse events in patients treated with immune checkpoint inhibitors: a prospective cohort study of cardiac adverse events
Agnese Losurdo, Cristina Panico, Chiara Catalano, Simone Serio, Laura Giordano, Lorenzo Monti, Federica Catapano, Stefano Figliozzi, Carla D’Andrea, Angelo Dipasquale, Pasquale Persico, Antonio Di Muzio, Marco Cremonesi, Alessandro Marchese, Maria Chiara Tronconi, Matteo Perrino, Giovanna Finocchiaro, Enrico Lugli, Marco Francone, Armando Santoro, Gianluigi Condorelli, Matteo Simonelli, Marinos Kallikourdis

Journal for ImmunoTherapy of Cancer Mar 2025, 13 (3) e010568; DOI: 10.1136/jitc-2024-010568
Blood TCTP as a potential biomarker associated with immunosuppressive features and poor clinical outcomes in metastatic gastric cancer
Hyung-Don Kim, Seyoung Jung, Yeong Hak Bang, Jiae Kim, Hee Jeong Kim, Hyung Eun Lee, Jaewon Hyung, Changhoon Yoo, Won-Tae Kim, Myeong-Jin Yoon, Hayoung Lee, Jeong-Hyun Ryou, Hyungsu Jeon, Hideyuki Yanai, Jeong Seok Lee, Gwanghee Lee, Min-Hee Ryu

Journal for ImmunoTherapy of Cancer Mar 2025, 13 (3) e010455; DOI: 10.1136/jitc-2024-010455
Enhanced thrombopoiesis supplies PD-L1 to circulating immune cells via the generation of PD-L1-expressing platelets in patients with lung cancer
Sung-Woo Lee, Saei Jeong, Young Ju Kim, Jeong Eun Noh, Kyung Na Rho, Hee-Ok Kim, Hyun-Ju Cho, Deok Hwan Yang, Eu Chang Hwang, Woo Kyun Bae, Sook Jung Yun, Ju Sik Yun, Cheol-Kyu Park, In-Jae Oh, Jae-Ho Cho

Journal for ImmunoTherapy of Cancer Feb 2025, 13 (2) e010193; DOI: 10.1136/jitc-2024-010193
Association of 5α-reductase inhibitor prescription with immunotherapy efficacy in metastatic renal cell carcinoma: a multicenter retrospective analysis
Bisheng Cheng, Jilin Wu, Ke Chen, Weijia Li, Jianghua Yang, WenTai Shangguan, Lin Yang, Wenxue Huang, Cunzhen Ma, Zhuohang Li, Boyuan Sun, Qiong Wang, Hai Huang, Peng Wu

Journal for ImmunoTherapy of Cancer Feb 2025, 13 (2) e011154; DOI: 10.1136/jitc-2024-011154
Stratification system with dual human endogenous retroviruses for predicting immunotherapy efficacy in metastatic clear-cell renal cell carcinoma
Xiaofan Lu, Yann-Alexandre Vano, Xiaoping Su, Virginie Verkarre, Cheng-Ming Sun, Wenxuan Cheng, Li Xu, Fangrong Yan, Salma Kotti, Wolf Hervé Fridman, Catherine Sautes-Fridman, Stéphane Oudard, Gabriel G. Malouf

Journal for ImmunoTherapy of Cancer Jan 2025, 13 (1) e010386; DOI: 10.1136/jitc-2024-010386
Safety and efficacy of PD-1 inhibitor (sintilimab) combined with transarterial chemoembolization as the initial treatment in patients with intermediate-stage hepatocellular carcinoma beyond up-to-seven criteria
Lixing Li, Xin Xu, Wentao Wang, Peiran Huang, Lei Yu, Zhenggang Ren, Jia Fan, Jian Zhou, Lan Zhang, Zheng Wang

Journal for ImmunoTherapy of Cancer Jan 2025, 13 (1) e010035; DOI: 10.1136/jitc-2024-010035

Main menu

Immune checkpoint inhibitors

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Immune checkpoint inhibitors

Pages